CA2054771A1 - Methode de traitement de l'hepatite - Google Patents

Methode de traitement de l'hepatite

Info

Publication number
CA2054771A1
CA2054771A1 CA002054771A CA2054771A CA2054771A1 CA 2054771 A1 CA2054771 A1 CA 2054771A1 CA 002054771 A CA002054771 A CA 002054771A CA 2054771 A CA2054771 A CA 2054771A CA 2054771 A1 CA2054771 A1 CA 2054771A1
Authority
CA
Canada
Prior art keywords
nucleoside
administered
use according
hepatitis
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002054771A
Other languages
English (en)
Inventor
Hiroaki Mitsuya
Jay H. Hoofnagle
Samuel Broder
Robert Yarchoan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2054771A1 publication Critical patent/CA2054771A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
CA002054771A 1989-05-15 1990-05-15 Methode de traitement de l'hepatite Abandoned CA2054771A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35150289A 1989-05-15 1989-05-15
US351,502 1989-05-15
PCT/US1990/002686 WO1990014091A1 (fr) 1989-05-15 1990-05-15 Procede de traitement de l'hepatite

Publications (1)

Publication Number Publication Date
CA2054771A1 true CA2054771A1 (fr) 1990-11-16

Family

ID=23381196

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002054771A Abandoned CA2054771A1 (fr) 1989-05-15 1990-05-15 Methode de traitement de l'hepatite

Country Status (5)

Country Link
EP (1) EP0472663A4 (fr)
JP (1) JPH04501857A (fr)
AU (1) AU5832990A (fr)
CA (1) CA2054771A1 (fr)
WO (1) WO1990014091A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108794T1 (de) * 1985-05-15 1994-08-15 Wellcome Found Therapeutische nucleoside und deren herstellung.
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
US4704357A (en) * 1985-09-30 1987-11-03 United States Of America As Represented By The Department Of Health And Human Services Immortalized T-lymphocyte cell line for testing HTLV-III inactivation
CA1327000C (fr) * 1987-08-07 1994-02-15 David L.J. Tyrrell Therapie antivirale pour l'hepatite b
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物

Also Published As

Publication number Publication date
AU5832990A (en) 1990-12-18
WO1990014091A1 (fr) 1990-11-29
EP0472663A4 (en) 1992-07-01
EP0472663A1 (fr) 1992-03-04
JPH04501857A (ja) 1992-04-02

Similar Documents

Publication Publication Date Title
US6596700B2 (en) Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosides
US6787526B1 (en) Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
CN1195526C (zh) 含对映体纯β－D－二氧戊环核苷的药物产品
CN100387237C (zh) 用于治疗乙型肝炎的β-L-2'-脱氧-核苷
AU2001263484A1 (en) Methods of treating hepatitis delta virus infection with beta-l-2'- deoxy-nucleosides
US20090247487A1 (en) Combination Therapy to Treat Hepatitis B Virus
KR100290132B1 (ko) 전신 염증 및 염증성 간염 치료용 피리미딘 누클레오티드 전구체
CN1431907A (zh) 治疗丁型肝炎病毒感染的方法
KR940010441B1 (ko) B형감염의 항비루스제
AU732120B2 (en) Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
CA2054771A1 (fr) Methode de traitement de l'hepatite
AU5659990A (en) Method of treatment of hepatitis
Lofgren et al. 2 ‘, 3’‐dideoxy‐3 ‘‐fluoroguanosine inhibits duck hepatitis B virus in vivo
Liu Antiviral drugs

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued